medigraphic.com
ISSN 1561-3186 (Digital)

2016, Número 1

<< Anterior Siguiente >>

Rev Acta Médica 2016; 17 (1)


Microbiota, probióticos, prebióticos y simbióticos

Mariño GA, Núñez VM, Barreto PJ

Idioma: Español
Referencias bibliográficas: 52
Paginas:
Archivo PDF: 406.29 Kb.


RESUMEN

Los nuevos estilos de vida han provocado el abandono de determinados hábitos saludables de alimentación. Es en este contexto donde han surgido los alimentos funcionales como aquellos que proveen beneficios a la salud. Actualmente se da gran importancia a la utilización de los alimentos funcionales para corregir las posibles “disfunciones o alteraciones de la microbiota intestinal, mediante la utilización de agentes bioterapéuticos (prebióticos, probióticos y simbióticos), que han sido catalogados como productos nutracéuticos; es decir, de origen natural, beneficiosos para la salud, con propiedades biológicas activas y capacidad preventiva y/o terapéutica definida. Se revisan algunos de los estudios más sólidos y recientes que abordan esta temática.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Mohammadi R, Mortazavian AM. Tehcnological aspects of prebiotics in probiotic fermented milks. Food Rev Int. 2011;27:192-212.

  2. Bigliardi B, Galati F. Innovation trends in the food industry: the case of functional foods. Trends in Food Science and Technology. 2013;31:118-29.

  3. Alberta NA, Aryee AN, Boye JI. Current and Emerging Trends in the Formulation and Manufacture of Nutraceuticals and Functional Food Products. In: Boye JI. Nutraceutical and functional food processing technology. (CD-ROM). 5th ed. Philadelphia: Wiley Blackwell; 2015.1-64.

  4. Johnson CL, Versalovic J. The human microbiome and its potential importance to pediatrics. Pediatrics. 2012;129:950-60.

  5. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489(7415):242-9.

  6. Suárez JE. Microbiota autóctona, probióticos y prebióticos. Nutr Hosp. 2015;31(Supl. 1):3-9.

  7. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-12.

  8. Eguiartea LE, Bonilla-Rosso G, Souza V., Metagenómica, genómica y ecología molecular: la nueva ecología en el bicentenario de Darwin. Tip Revista Especializada en Ciencias Químico-Biológicas [en línea] 2008 Junio 11; [Fecha de consulta: 29 de enero de 2016]. Disponible en: http://www.redalyc.org/articulo.oa?id=43211943005

  9. Hernández Hernández A, Coronel Rodríguez C, Monge Zamorano M, Quintana Herrera C. Microbiota, probióticos, prebióticos y simbióticos. Pediatría Integral. 2015;19(5):337-54.

  10. Bauerl C, Pérez‐Martínez G, Yan F, Polk DB, Monedero V. Functional analysis of the p40 and p75 Proteins from Lactobacillus casei BL23. J Mol Microbiol Biotechnol. 2010;19:231‐41.

  11. Carpenter S, O'Neill LA. How important are Toll-like receptors for antimicrobial responses? Cell Microbiol. 2007;9(8):1891-1901.

  12. Bernardo D. Células dendríticas del intestino humano como controladoras de la inmunidad mucosa. Rev Esp Enferm Dig. 2013;105;5:279-90.

  13. World Gastroenterology Organization (WGO). Probióticos y prebióticos. En: Guías Mundiales de la Organización Mundial de Gastroenterología (monografía en Internet). Octubre 2011. Disponible en: http://www.worldgastroenterology.org/probioticsprebiotics. html

  14. De Vos WM, de Vos EA. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev. 2012;70 (Suppl 1):S45-S56.

  15. Khanna S, Tosh PK. A clinician’s primer on the role of the microbiome in human health and disease. Mayo Clin Proc. 2014;89(1):107-14.

  16. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174-80.

  17. Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach J, Hörmannsperger G, et al. Safety assessment of probiotics for human use. Gut Microbes. 2010;1:164-85.

  18. Lilly DM, Stillwell RH. Probiotics: Growth-promoting factors produced by microorganisms. Science. 1965;147(3659):747-8.

  19. Guarner F, Requena T, Marcos A. Declaraciones consensuadas del Workshop “Probióticos y salud: evidencia científica”. Nutr Hosp. 2010; 25(5):700-4.

  20. Guarner F, Requena T, Marcos A. Consensus statements from the Workshop “Probiotics and Health: Scientific evidence”. Nutr Hosp. 2010;25:700-4.

  21. Chen YE, Tsao H. The skin microbiome: current perspectives and future challenges. J Am Acad Dermatol. 2013;69:143-55.

  22. Sommer F, Bäckhed F. The gut microbiota─masters of host development and physiology. Nat Rev Microbiol. 2013;11: 227-38 .

  23. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506-14.

  24. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, Angenent LT, Ley RE. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA. 2011 March 15;108 (Suppl 1):4578-85.

  25. Rowland I, Capurso L, Collins K, Cummings J, Delzenne N, Goulet O, et al. Current level of consensus on probiotic science. Gut Microbes. 2010;1:436-39.

  26. Sommer F, Bäckhed F. The gut microbiota--masters of host development and physiology. Nat Rev Microbiol. 2013;11:227-38.

  27. Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One. 2010;5:e10197.

  28. Zhou X, R. M. Brotman, P. Gajer, Z. Abdo, U. Schüette, S. Ma, J. Ravel & L. J. Forney. Recent advances in understanding the microbiology of the female reproductive tract and the causes of premature birth. Infect. Dis Obstet Gynecol. 2010:737‐425.

  29. Floch MH, Walker WA, Madsen K, Sanders ME, Macfarlane GT, Flint HJ, et al. Recommendations for probiotic use─2011 update. J Clin Gastroenterol. 2011;45:S 168-71.

  30. Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Mol Aspects Med. 2013;34(1):39-58.

  31. Finucane MM, Sharpton TJ, Laurent TJ, Pollard KS. A taxonomic signature of obesity in the microbiome? Getting to the guts of the matter. PLoS One. 2014 Jan 8;9(1):e84689. doi: 10.1371/journal.pone.0084689.

  32. Walters WA, Xu Z, Knight R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett 2014;588(22):4223-33.

  33. Mahan LK, Swift KM. Capítulo 27. Tratamiento nutricional médico en las reacciones adversas a los alimentos: alergias e intolerancias alimentarias. En: Mahan LK, Escott Stump S, Raymond JL. Krause Dietoterapia (13 Ed.). España: Elsevier; 2013. p. 562- 90.

  34. AAQQUIIITur Marí JA. Componentes no nutritivos de interés nutricional, Módulo II.8. En: Libro Blanco de la Nutrición en España. Fundación Española de la Nutrición (FEN) y Agencia Española de Seguridad Alimentaria y Nutrición (AESAN). Madrid, 2013: 179-87.

  35. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. British Journal of Nutrition. 2010;104:S1-S63.

  36. Karimi R, Azizib MH, Ghasemlouc M, Vaziri M. Application of inulin in cheese as prebiotic, fat replacer and texturizer: a review. Carbohydrate Polymers. 2015;119:85- 100.

  37. Gibson GR, Probert HM, Van Loo JAE, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev. 2004;17:257-9.

  38. Lamsal BP. Production, health aspects and potential food uses of dairy prebiotic galactooligosaccharides. J Sci Food Agric. 2012;92:2020-28.

  39. Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A, et al . Dietary prebiotics: current status and new definition. Food Sci Technol Bull. 2010;7:1-19.

  40. Rastall RA. Functional oligosaccharides: application and manufacture. Annu Rev Food Sci Technol. 2010;1:305-39.

  41. Van de Wiele T, Boon N, Possemiers S, Jacobs H, Verstraete W. Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol. 2006;102:452-60.

  42. Macfarlane GT, Steed H, Macfarlane S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol. 2008;104:305-44.

  43. Villamiel M, Montilla A, Olano A, Corzo N. Production and bioactivity of oligosaccharides derived from lactose. En: Food Oligosaccharides: Production, Analysis and Bioactivity. ISBN: 978-1-118-42649-4. Eds. F. Javier Moreno y M. Luz Sanz. Chichester, United Kingdom: Wiley-Blackwell; 2014. p.137-67.

  44. Schuster-Wolff-Bühring R, Fischer L, Hinrichs J. Production and physiological action of the disaccharide lactulose. Int Dairy J. 2010;20:731-41.

  45. Panesar PS, Kumari S. Lactulose: Production, purification and potential applications. Biotechnol Adv. 2011;29:940-8.

  46. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2010. Scientific opinion on the substantiation of health claims related to lactulose and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 806) and reduction in intestinal transit time (ID 807) pursuant to Article 13(1) of Regulation (EC) No. 1924/2006. EFSA Journal 8, 1806-1821.

  47. Padilla B, Ruiz-Matute AI, Belloch C, Cardelle-Cobas A, Corzo N, Manzanares P. Evaluation of oligosaccharide synthesis from lactose and lactulose using - galactosidases from Kluyveromyces aisolated from artisanal cheeses. J Agric Food Chem. 2012;60:5134-41.

  48. Rodríguez-Colinas B, Poveda A, Jiménez-Barbero J, Ballesteros AO, Plou FJ. Galacto-oligosaccharide synthesis from lactose solution or skim milk using the ßgalactosidase from Bacillus circulans. J Agric Food Chem. 2012;60:6391-98.

  49. Venema K. Intestinal fermentation of lactose and prebiotic lactose derivatives, including human milk oligosaccharides. Int Dairy J. 2012;22:123-40.

  50. Barile D, Rastall RA. Human milk and related oligosaccharides as prebiotics. Curr Opin Biotechnol. 2013;24:214-9.

  51. Kellow NJ, Coughlan MT, Reida CM. Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. British Journal of Nutrition. 2014;111:1147-61.

  52. Macfarlane GT, Steed H, Macfarlane S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. Journal of Applied Microbiology. 2008;104:305-44.




2020     |     www.medigraphic.com